pharmaceuticals for treating organic mental disorders; pharmaceuticals for treating symptomatic mental disorders; pharmaceuticals for treating mental Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceuticals for treating organic mental disorders; pharmaceuticals for treating symptomatic mental disorders; pharmaceuticals for treating mental and behavioural disorders; pharmaceuticals for treating endocrine; Pharmaceuticals for treating nutritional and metabolic diseases; pharmaceuticals for treating degenerative cerebral disease; pharmaceuticals for treating dementia; pharmaceuticals for treating dementias; pharmaceuticals for treating mental and behavioural disorders; pharmaceuticals for treating organic amnesic syndrome; pharmaceuticals for treating mental and behavioural disorders due to use of alcohol; pharmaceuticals for treating hallucinosis; Pharmaceuticals for treating mental disorders; Pharmaceuticals for treating schizophrenic disorder Pharmaceuticals for treating depression; Pharmaceuticals for treating mood disorders; pharmaceuticals for treating mental and behavioural disorders due to psychoactive substance use; pharmaceuticals for treating schizophrenia; Pharmaceuticals for treating schizotypal and delusional disorders; pharmaceuticals for treating neurotic disorders; Pharmaceuticals for treating stress-related disorders and somatoform disorders; pharmaceuticals for treating behavioural syndromes associated with physiological disturbances and physical factors; pharmaceuticals for treating personality and behavioural disorders due to brain disease; Pharmaceuticals for treating damage and dysfunction; pharmaceuticals for treating disorders of adult personality; pharmaceuticals for treating disorders of behaviour; Pharmaceuticals for treating disorders of psychological development; Pharmaceuticals for treating behavioural and emotional disorders with onset usually occurring in childhood and adolescence; Pharmaceuticals for treating Bipolar disorder; Pharmaceuticals for treating Body dysmorphic disorder; Pharmaceuticals for treating borderline personality disorder; Pharmaceuticals for treating Bulimia; Pharmaceuticals for treating Claustrophobia; Pharmaceuticals for treating Dissociative disorders; Pharmaceuticals for treating Eating disorders; Pharmaceuticals for treating Hoarding disorder; Pharmaceuticals for treating Munchausen's syndrome; Pharmaceuticals for treating Obsessive compulsive disorder; Pharmaceuticals for treating Panic disorder; Pharmaceuticals for treating Personality disorder; Pharmaceuticals for treating Phobias; Pharmaceuticals for treating Postnatal depression; Pharmaceuticals for treating Postpartum psychosis; Pharmaceuticals for treating Post-traumatic stress disorder; Pharmaceuticals for treating Psychosis; Pharmaceuticals for treating Schizophrenia. .

Class [42]
Computer & Software Services & Scientific Services

Development of pharmaceutical preparations and medicines; Research of pharmaceuticals; Research relating to pharmaceuticals; Testing of pharmaceuticals; Conducting clinical trials for pharmaceutical products; Consultancy in the field of pharmaceutical research; Conducting early evaluations in the field of new pharmaceuticals; Inspection of pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical product evaluation; Laboratory research services relating to pharmaceuticals; Providing information about the results of clinical trials for pharmaceutical products. .

Mark Details

Serial Number

UK00003719527

Mark Type

Word

Kind of mark

Individual

Total Brain Health